Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.

作者: Sophie Pilleron , Hadrien Charvat , Marzieh Araghi , Melina Arnold , Miranda M. Fidler‐Benaoudia

DOI: 10.1002/IJC.33326

关键词:

摘要: We sought to understand the role of stage at diagnosis in observed age disparities colon cancer survival among people aged 50 99 years using population-based registry data from seven high-income countries: Australia, Canada, Denmark, Ireland, New Zealand, Norway and United Kingdom. used incidence for period 2010 2014. estimated 3-year net survival, as well conditional on surviving least 6 months 1 year after diagnosis, by country (categorised localised, regional or distant) flexible parametric excess hazard regression models. In all countries, increasing was associated with lower survival. For example, (95% confidence interval) 81% (80-82) 64 olds 58% (56-60) 85 74% (73-74) 39% (39-40) Kingdom, respectively. Those distant had largest difference between youngest oldest patients. Excess mortality patients localised cancers during first diagnosis. Older diagnosed (and some countries regional) who survived experienced same their younger counterparts. Further studies examining other prognostic clinical factors such comorbidities treatment, socioeconomic are warranted gain further understanding

参考文章(44)
Ula Nur, Lorraine G Shack, Bernard Rachet, James R Carpenter, Michel P Coleman, Modelling relative survival in the presence of incomplete data: a tutorial International Journal of Epidemiology. ,vol. 39, pp. 118- 128 ,(2010) , 10.1093/IJE/DYP309
Roberta De Angelis, Milena Sant, Michel P Coleman, Silvia Francisci, Paolo Baili, Daniela Pierannunzio, Annalisa Trama, Otto Visser, Hermann Brenner, Eva Ardanaz, Magdalena Bielska-Lasota, Gerda Engholm, Alice Nennecke, Sabine Siesling, Franco Berrino, Riccardo Capocaccia, None, Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study The Lancet Oncology. ,vol. 15, pp. 23- 34 ,(2014) , 10.1016/S1470-2045(13)70546-1
S. Hill, D. Sarfati, T. Blakely, B. Robson, G. Purdie, J. Chen, E. Dennett, D. Cormack, R. Cunningham, K. Dew, T. McCreanor, I. Kawachi, Survival Disparities in Indigenous and Non-Indigenous New Zealanders with Colon Cancer: The Role of Patient Comorbidity, Treatment and Health Service Factors Journal of Epidemiology and Community Health. ,vol. 64, pp. 117- 123 ,(2010) , 10.1136/JECH.2008.083816
Alberto Quaglia, Andrea Tavilla, Lorraine Shack, Hermann Brenner, Maryska Janssen-Heijnen, Claudia Allemani, Marc Colonna, Enrico Grande, Pascale Grosclaude, Marina Vercelli, EUROCARE Working Group, The cancer survival gap between elderly and middle-aged patients in Europe is widening European Journal of Cancer. ,vol. 45, pp. 1006- 1016 ,(2009) , 10.1016/J.EJCA.2008.11.028
Diana Sarfati, Bogda Koczwara, Christopher Jackson, The impact of comorbidity on cancer and its treatment CA: A Cancer Journal for Clinicians. ,vol. 66, pp. 337- 350 ,(2016) , 10.3322/CAAC.21342
Jason Gurney, Diana Sarfati, James Stanley, The impact of patient comorbidity on cancer stage at diagnosis British Journal of Cancer. ,vol. 113, pp. 1375- 1380 ,(2015) , 10.1038/BJC.2015.355
Eric Van Cutsem, Andrés Cervantes, Rene Adam, Alberto Sobrero, JH Van Krieken, D Aderka, E Aranda Aguilar, Alberto Bardelli, A Benson, G Bodoky, Fortunato Ciardiello, André D'Hoore, E Diaz-Rubio, J-Y Douillard, M Ducreux, Alfredo Falcone, A Grothey, T Gruenberger, Karin Haustermans, V Heinemann, P Hoff, C-H Köhne, R Labianca, P Laurent-Puig, B Ma, T Maughan, K Muro, N Normanno, P Österlund, WJG Oyen, D Papamichael, G Pentheroudakis, P Pfeiffer, TJ Price, C Punt, J Ricke, A Roth, R Salazar, W Scheithauer, HJ Schmoll, J Tabernero, J Taïeb, Sabine Tejpar, H Wasan, T Yoshino, A Zaanan, D Arnold, None, ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Annals of Oncology. ,vol. 27, pp. 1386- 1422 ,(2016) , 10.1093/ANNONC/MDW235
Amandine Gouverneur, Magali Rouyer, Angela Grelaud, Philip Robinson, Françoise Colombani, Eric Terrebonne, Denis Smith, Annie Fourrier-Réglat, Pernelle Noize, How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital. Fundamental & Clinical Pharmacology. ,vol. 31, pp. 104- 109 ,(2017) , 10.1111/FCP.12243
Yin Zhou, Gary A. Abel, Willie Hamilton, Kathy Pritchard-Jones, Cary P. Gross, Fiona M. Walter, Cristina Renzi, Sam Johnson, Sean McPhail, Lucy Elliss-Brookes, Georgios Lyratzopoulos, Diagnosis of cancer as an emergency: a critical review of current evidence Nature Reviews Clinical Oncology. ,vol. 14, pp. 45- 56 ,(2017) , 10.1038/NRCLINONC.2016.155
Maja Pohar Perme, Jacques Estève, Bernard Rachet, Analysing population-based cancer survival – settling the controversies BMC Cancer. ,vol. 16, pp. 933- ,(2016) , 10.1186/S12885-016-2967-9